Published in Medicine and Law Weekly, January 19th, 2007
"This re-submission is the culmination of a comprehensive and thorough review process conducted by Astellas Pharma US, Inc., Cardiome and outside consultants," stated Dr. Charles Fisher, executive vice president and chief medical officer of Cardiome. "With the inclusion of an additional 150 patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly